William K. Oh
William K. Oh, an expert in the management of genitourinary malignancies, including prostate, renal, bladder, and testicular cancers, joined the Mount Sinai School of Medicine as a Chief of the Division of Hematology and Medical Oncology, Codirector of the Prostate Cancer Program, and Associate Director for Clinical Research for The Tisch Cancer Institute in 2009. His research interests include the role of chemotherapy and novel therapeutics in advanced prostate cancer. A leading investigator in the use of neoadjuvant chemotherapy in men with high-risk localized prostate cancer, he has served as the principal investigator of multiple clinical trials in prostate and other GU cancers. In addition, he developed a large clinical database and specimen repository for GU cancers which has enrolled over 6,000 patients with prostate, renal, and bladder cancer in the past decade. Oh has authored more than 200 original articles, reviews, and book chapters on topics related to prostate, renal, bladder, and testicular cancers. He has recently edited 3 books on prostate cancer. He has served on the Cancer Education Committee of the American Society of Clinical Oncology (ASCO) and acts a core Member of the Genitourinary Committee of Cancer and Leukemia Group B (CALGB). In addition to reviewing for prominent journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Cancer, Oh coedits Testicular Cancer for Up to Date and is on the editorial boards of CA, A Cancer Journal for Clinicians and American Journal of Hematology and Oncology. Oh received his M.D. degree from the New York University School of Medicine, USA. He completed his internship and residency in internal medicine at the Brigham and Women’s Hospital in Boston. Oh subsequently completed a fellowship in medical oncology at the Dana-Farber Cancer Institute in 1997.
Biography Updated on 21 January 2013